Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy Denise Bernhardt,1–3,* Sophie Aufderstrasse,1,2,* Laila König,1–3 Sebastian Adeberg,1–4 Farastuk Bozorgmehr,5,6 Petros Christopoulos,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bernhardt, Denise (VerfasserIn) , Aufderstraße, Sophie (VerfasserIn) , König, Laila (VerfasserIn) , Adeberg, Sebastian (VerfasserIn) , Bozorgmehr, Farastuk (VerfasserIn) , Christopoulos, Petros (VerfasserIn) , El-Shafie, Rami (VerfasserIn) , Hörner-Rieber, Juliane (VerfasserIn) , Kappes, Jutta (VerfasserIn) , Thomas, Michael (VerfasserIn) , Herth, Felix (VerfasserIn) , Steins, Martin (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Rieken, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 November 2018
In: Cancer management and research
Year: 2018, Jahrgang: 10, Pages: 6563-6569
ISSN:1179-1322
DOI:10.2147/CMAR.S180990
Online-Zugang:Verlag, Volltext: https://doi.org/10.2147/CMAR.S180990
Verlag, Volltext: https://www.dovepress.com/impact-of-inflammatory-markers-on-survival-in-patients-with-limited-di-peer-reviewed-article-CMAR
Volltext
Verfasserangaben:Denise Bernhardt, Sophie Aufderstrasse, Laila König, Sebastian Adeberg, Farastuk Bozorgmehr, Petros Christopoulos, Rami A El Shafie, Juliane Hörner-Rieber, Jutta Kappes, Michael Thomas, Felix Herth, Martin Steins, Jürgen Debus, Stefan Rieken

MARC

LEADER 00000caa a2200000 c 4500
001 1670334112
003 DE-627
005 20230427055739.0
007 cr uuu---uuuuu
008 190731s2018 xx |||||o 00| ||eng c
024 7 |a 10.2147/CMAR.S180990  |2 doi 
035 |a (DE-627)1670334112 
035 |a (DE-599)KXP1670334112 
035 |a (OCoLC)1341234904 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bernhardt, Denise  |d 1987-  |e VerfasserIn  |0 (DE-588)1074875338  |0 (DE-627)832630691  |0 (DE-576)443070970  |4 aut 
245 1 0 |a Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy  |c Denise Bernhardt, Sophie Aufderstrasse, Laila König, Sebastian Adeberg, Farastuk Bozorgmehr, Petros Christopoulos, Rami A El Shafie, Juliane Hörner-Rieber, Jutta Kappes, Michael Thomas, Felix Herth, Martin Steins, Jürgen Debus, Stefan Rieken 
264 1 |c 30 November 2018 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 31.07.2019 
520 |a Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy Denise Bernhardt,1&ndash;3,* Sophie Aufderstrasse,1,2,* Laila K&ouml;nig,1&ndash;3 Sebastian Adeberg,1&ndash;4 Farastuk Bozorgmehr,5,6 Petros Christopoulos,5,6 Rami A El Shafie,1,2 Juliane H&ouml;rner-Rieber,1&ndash;3 Jutta Kappes,6,7 Michael Thomas,5,6 Felix Herth,6,7 Martin Steins,5 J&uuml;rgen Debus,1&ndash;4 Stefan Rieken1&ndash;3 1Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany; 2Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; 3Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; 4Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; 5Department of Thoracic Oncology, Thoraxklinik, Heidelberg University, Translational Lung Research Centre Heidelberg (TLRC-H), Heidelberg, Germany; 6German Centre for Lung Research (DZL), Heidelberg, Germany; 7Department of Pneumology, Thoraxklinik, Heidelberg University, Heidelberg, Germany *These authors contributed equally to this work Background: Systemic inflammation appears to play a role in the progression of numerous solid tumors by promoting tumor proliferation. Our current study aimed to evaluate the role of inflammatory markers in limited disease (LD) small-cell lung cancer (SCLC) patients undergoing thoracic chemoradiotherapy (TCR). Patients and methods: We retrospectively analyzed a total number of 350 SCLC patients diagnosed with LD SCLC who received TCR between 1999 and 2017 and had available blood tests within 2 weeks prior to the start of TCR. Serum C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), lactate dehydrogenase (LDH), hemoglobin (Hb) levels, and platelet count (Pc) were evaluated as potential inflammatory markers. Kaplan&ndash;Meier survival analysis was performed for overall survival (OS). For comparison of survival curves, the log-rank (&shy;Mantel&ndash;Cox) test was used. Univariate and multivariate Cox proportional HRs were used to assess the influence of cofactors on OS. Results: Univariate analysis for OS revealed a statistically significant effect for LDH >400 U/L (HR 2.05 U/L; 95% CI 1.29&ndash;3.26 U/L;&nbsp;P=0.002), prophylactic cranial irradiation (PCI; HR 0.58; 95% CI 0.40&ndash;0.85;&nbsp;P=0.005), CRP >50 mg/L (HR 1.49 mg/L; 95% CI 1.05&ndash;2.10 mg/L;&nbsp;P=0.026), and Karnofsky performance scale (KPS) <70% (HR 1.35%; 95% CI 1.02&ndash;1.80%;&nbsp;P=0.035). NLR, age (>70 years), Hb levels, and Pc did not influence survival. In multivariate analysis, OS was significantly affected by PCI (HR 0.64; 95% CI 0.43&ndash;0.94; P=0.026), LDH >400 U/L (HR 1.91 U/L; 95% CI 1.21&ndash;3.05 U/L;&nbsp;P=0.006), and CRP >50 mg/L (HR 1.43 mg/L; 95% CI 1.01&ndash;2.04 mg/L;&nbsp;P=0.045). KPS (&le;70%) did not influence survival in multivariate analysis. Conclusion: Elevated CRP and LDH seem to be the independent prognostic factors for OS in LD SCLC patients undergoing TCR. However, elevated NLR was not found to be an independent prognostic factor for OS if taken prior to TCR. LDH and CRP are easily available blood tests and do not require additional resources for routine use and could be useful for clinical decision making. Keywords: small-cell lung cancer, limited disease, comorbidity, NLR, LDH, CRP 
700 1 |a Aufderstraße, Sophie  |d 1989-  |e VerfasserIn  |0 (DE-588)1160095051  |0 (DE-627)1023240653  |0 (DE-576)505508516  |4 aut 
700 1 |a König, Laila  |d 1986-  |e VerfasserIn  |0 (DE-588)1053640579  |0 (DE-627)790403315  |0 (DE-576)409584282  |4 aut 
700 1 |a Adeberg, Sebastian  |d 1984-  |e VerfasserIn  |0 (DE-588)1049743377  |0 (DE-627)782574467  |0 (DE-576)403727774  |4 aut 
700 1 |a Bozorgmehr, Farastuk  |d 1979-  |e VerfasserIn  |0 (DE-588)141921811  |0 (DE-627)632526734  |0 (DE-576)326848150  |4 aut 
700 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
700 1 |a El-Shafie, Rami  |d 1989-  |e VerfasserIn  |0 (DE-588)110057378X  |0 (DE-627)859521427  |0 (DE-576)469743859  |4 aut 
700 1 |a Hörner-Rieber, Juliane  |d 1985-  |e VerfasserIn  |0 (DE-588)1025307631  |0 (DE-627)722020511  |0 (DE-576)370188039  |4 aut 
700 1 |a Kappes, Jutta  |e VerfasserIn  |0 (DE-588)107507195X  |0 (DE-627)832912832  |0 (DE-576)175883572  |4 aut 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
700 1 |a Herth, Felix  |e VerfasserIn  |0 (DE-588)1016095236  |0 (DE-627)705477568  |0 (DE-576)351509925  |4 aut 
700 1 |a Steins, Martin  |d 1971-  |e VerfasserIn  |0 (DE-588)121323900  |0 (DE-627)705384837  |0 (DE-576)292647379  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Rieken, Stefan  |d 1979-  |e VerfasserIn  |0 (DE-588)135553385  |0 (DE-627)567062570  |0 (DE-576)278641725  |4 aut 
773 0 8 |i Enthalten in  |t Cancer management and research  |d Albany, Auckland : Dove Medical Press, 2009  |g 10(2018), Seite 6563-6569  |h Online-Ressource  |w (DE-627)606030840  |w (DE-600)2508013-1  |w (DE-576)309422779  |x 1179-1322  |7 nnas  |a Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy 
773 1 8 |g volume:10  |g year:2018  |g pages:6563-6569  |g extent:7  |a Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy 
856 4 0 |u https://doi.org/10.2147/CMAR.S180990  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.dovepress.com/impact-of-inflammatory-markers-on-survival-in-patients-with-limited-di-peer-reviewed-article-CMAR  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190731 
993 |a Article 
994 |a 2018 
998 |g 135553385  |a Rieken, Stefan  |m 135553385:Rieken, Stefan  |d 910000  |d 911400  |e 910000PR135553385  |e 911400PR135553385  |k 0/910000/  |k 1/910000/911400/  |p 14  |y j 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 13 
998 |g 121323900  |a Steins, Martin  |m 121323900:Steins, Martin  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PS121323900  |e 950000PS121323900  |e 950900PS121323900  |e 50000PS121323900  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 12 
998 |g 1016095236  |a Herth, Felix  |m 1016095236:Herth, Felix  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1016095236  |e 950000PH1016095236  |e 950900PH1016095236  |e 50000PH1016095236  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 11 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |e 50000PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 10 
998 |g 107507195X  |a Kappes, Jutta  |m 107507195X:Kappes, Jutta  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PK107507195X  |e 950000PK107507195X  |e 950900PK107507195X  |e 50000PK107507195X  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 9 
998 |g 1025307631  |a Hörner-Rieber, Juliane  |m 1025307631:Hörner-Rieber, Juliane  |d 910000  |d 911400  |e 910000PH1025307631  |e 911400PH1025307631  |k 0/910000/  |k 1/910000/911400/  |p 8 
998 |g 110057378X  |a El-Shafie, Rami  |m 110057378X:El-Shafie, Rami  |d 910000  |d 911400  |e 910000PE110057378X  |e 911400PE110057378X  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |e 50000PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 6 
998 |g 141921811  |a Bozorgmehr, Farastuk  |m 141921811:Bozorgmehr, Farastuk  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PB141921811  |e 950000PB141921811  |e 950900PB141921811  |e 50000PB141921811  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 5 
998 |g 1049743377  |a Adeberg, Sebastian  |m 1049743377:Adeberg, Sebastian  |d 910000  |d 911400  |d 50000  |e 910000PA1049743377  |e 911400PA1049743377  |e 50000PA1049743377  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 4 
998 |g 1053640579  |a König, Laila  |m 1053640579:König, Laila  |d 910000  |d 911400  |e 910000PK1053640579  |e 911400PK1053640579  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 1160095051  |a Aufderstrasse, Sophie  |m 1160095051:Aufderstrasse, Sophie  |d 910000  |d 911400  |e 910000PA1160095051  |e 911400PA1160095051  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 1074875338  |a Bernhardt, Denise  |m 1074875338:Bernhardt, Denise  |d 910000  |d 911400  |e 910000PB1074875338  |e 911400PB1074875338  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1670334112  |e 3501743793 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1670334112","physDesc":[{"extent":"7 S."}],"origin":[{"dateIssuedDisp":"30 November 2018","dateIssuedKey":"2018"}],"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"issn":["1179-1322"],"eki":["606030840"],"zdb":["2508013-1"]},"title":[{"title_sort":"Cancer management and research","title":"Cancer management and research"}],"part":{"year":"2018","pages":"6563-6569","extent":"7","text":"10(2018), Seite 6563-6569","volume":"10"},"origin":[{"publisher":"Dove Medical Press","publisherPlace":"Albany, Auckland","dateIssuedKey":"2009","dateIssuedDisp":"2009-"}],"pubHistory":["1.2009 -"],"disp":"Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapyCancer management and research","physDesc":[{"extent":"Online-Ressource"}],"recId":"606030840"}],"person":[{"display":"Bernhardt, Denise","family":"Bernhardt","role":"aut","given":"Denise"},{"given":"Sophie","role":"aut","family":"Aufderstraße","display":"Aufderstraße, Sophie"},{"given":"Laila","role":"aut","family":"König","display":"König, Laila"},{"display":"Adeberg, Sebastian","family":"Adeberg","given":"Sebastian","role":"aut"},{"given":"Farastuk","role":"aut","family":"Bozorgmehr","display":"Bozorgmehr, Farastuk"},{"display":"Christopoulos, Petros","family":"Christopoulos","given":"Petros","role":"aut"},{"role":"aut","given":"Rami","family":"El-Shafie","display":"El-Shafie, Rami"},{"role":"aut","given":"Juliane","family":"Hörner-Rieber","display":"Hörner-Rieber, Juliane"},{"display":"Kappes, Jutta","family":"Kappes","given":"Jutta","role":"aut"},{"family":"Thomas","role":"aut","given":"Michael","display":"Thomas, Michael"},{"display":"Herth, Felix","family":"Herth","role":"aut","given":"Felix"},{"display":"Steins, Martin","role":"aut","given":"Martin","family":"Steins"},{"display":"Debus, Jürgen","family":"Debus","given":"Jürgen","role":"aut"},{"family":"Rieken","given":"Stefan","role":"aut","display":"Rieken, Stefan"}],"title":[{"title_sort":"Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy","title":"Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"note":["Gesehen am 31.07.2019"],"name":{"displayForm":["Denise Bernhardt, Sophie Aufderstrasse, Laila König, Sebastian Adeberg, Farastuk Bozorgmehr, Petros Christopoulos, Rami A El Shafie, Juliane Hörner-Rieber, Jutta Kappes, Michael Thomas, Felix Herth, Martin Steins, Jürgen Debus, Stefan Rieken"]},"id":{"eki":["1670334112"],"doi":["10.2147/CMAR.S180990"]}} 
SRT |a BERNHARDTDIMPACTOFIN3020